By using DiabetesTimes.co.uk, you agree to our terms and use of cookies to enhance your experience.

Third type 1 diabetes comic is released

By Editor
8th December 2020
Type 1 diabetes

The third edition of a comic series dedicated to those living with type 1 diabetes is being released before Christmas.

‘Type 1: S.T.I.G.M.A’, which is inspired by the Ian Fleming character James Bond, will be available to download internationally for free from 12pm, on Friday December 18 from the Revolve Comics website.

This comic publication is the latest in this series, developed as a collaborative project between Revolve Comics and leading diabetes consultants Professor Partha Kar, of Portsmouth Hospitals NHS Trust and Dr Mayank Patel, of University Hospital Southampton NHS Foundation Trust.

The previous two issues, Type 1: Origins and  Type 1: Attack of the Ketones, are still available to read for free online.

Dr Patel said: “These comics have become hugely popular with young people who are coming to terms with their diagnosis or who are experiencing some challenges in managing their condition. Their friends and family have also found them informative.

“These comics always seek to use language that young people understand and we’ve often been told that they find this content far more engaging than other ‘traditional’ paper based or online resources, that cover similar issues. Each issue is always informed by real world type 1 diabetes themes and is always reviewed by individuals with type 1 diabetes before it is released.

“Our comics seek to address many different diabetes-related issues in a fun (but informative!) way, which can help reduce any concerns the reader may have had, or encourage them to talk more openly about what might have been troubling them. We encourage and are grateful for any support that fellow healthcare professionals, parents, carers and schools can give, to get behind this project and make these comics as widely accessible as they can be.”

To find out more information, click here.

Comments (0)

Register an account or login to comment